Eupraxia Pharmaceuticals Announces CFO Succession

-  Bruce Cousins is retiring, and former CFO Alex Rothwell will assume the role

VICTORIA, BC, Feb. 18, 2025 /PRNewswire/ - Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (NASDAQ: EPRX) (TSX: EPRX), a clinical-stage biotechnology company, today announced that it has appointed Alex Rothwell as the Company's new Chief Financial Officer, effective immediately.

Read more at prnewswire.com